tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Kymera Therapeutics management to meet with B. Riley
PremiumThe FlyKymera Therapeutics management to meet with B. Riley
21d ago
Kymera Therapeutics price target raised to $54 from $51 at BofA
Premium
The Fly
Kymera Therapeutics price target raised to $54 from $51 at BofA
23d ago
Kymera Therapeutics Announces Public Offering to Raise Funds
Premium
Company Announcements
Kymera Therapeutics Announces Public Offering to Raise Funds
25d ago
Kymera Therapeutics price target raised to $59 from $55 at BTIG
PremiumThe FlyKymera Therapeutics price target raised to $59 from $55 at BTIG
26d ago
Kymera Therapeutics price target lowered to $53 from $57 at Wells Fargo
Premium
The Fly
Kymera Therapeutics price target lowered to $53 from $57 at Wells Fargo
27d ago
Optimistic Outlook for Kymera Therapeutics Amid Strategic Partnerships and Strong KT-621 Prospects
Premium
Ratings
Optimistic Outlook for Kymera Therapeutics Amid Strategic Partnerships and Strong KT-621 Prospects
27d ago
Kymera Therapeutics Partners with Gilead for Oncology Treatment
PremiumCompany AnnouncementsKymera Therapeutics Partners with Gilead for Oncology Treatment
27d ago
Kymera Therapeutics Advances KT-485 in Sanofi Collaboration
Premium
Company Announcements
Kymera Therapeutics Advances KT-485 in Sanofi Collaboration
27d ago
Gilead sees Kymera deal lowering 2025 EPS by 2c-3c
Premium
The Fly
Gilead sees Kymera deal lowering 2025 EPS by 2c-3c
27d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100